Yide Medical Reports H1 2020 Net Loss of RMB 1.30 Million Amid 85.85% Revenue Decline Due to Pandemic Disruptions

Source: Wabei.com

Wabei.com, August 24 news,EDER Medical(839056) Recently released its 2020 semi-annual report. In the first half of 2020, the company achieved operating revenue of RMB 8,291,911.59, a year-on-year decrease of 85.85%; the net profit attributable to shareholders of the listed company was RMB -1,297,878.72, turning from profit to loss compared to the same period last year.

At the end of the reporting period, the Company’s total assets amounted to RMB 96,555,292.15, representing a decrease of 7.90% compared to the beginning of the period; the net assets attributable to shareholders of the listed company totaled RMB 81,119,578.23, representing a decrease of 1.57% compared to the beginning of the period.

It is understood that during the reporting period, EDER Medical reported an operating income of RMB 8,291,911.59, a year-on-year decrease of 85.85%, and a net profit of -RMB 1,297,878.72. The intraocular lens project was under construction, and the company’s wholly-owned subsidiary, Hanghou Juming Medical Device Co., Ltd., incurred a loss of RMB 1,501,078.03.

The decline in core business was attributed to the impact of the pandemic, as sales and installation personnel were unable to travel before April this year, significantly affecting the company’s operations. Sales of the new product, the surgical microscope, were essentially at a standstill.

According to data from Wabei.com, EDER Medical is guided by high-tech innovation, combining electronic control with mechanical design for the research and development, production, and sales ofMicroPort MedicalBasic Equipment – Surgical Microscope. The product line covers ophthalmology, neurosurgery, spinal surgery, orthopedics, otorhinolaryngology, and related peripheral equipment for microsurgery. It is a leading manufacturer and supplier of domestically produced surgical microscopes in China.